HANSA BIOPHARMA LIMITEDActive

Company number 08361712Private limited companyIncorporated 2013
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.

Key figures

£283,932+162.3%
Net assets 2024
+162.3%
Average annual growth 2022–2024
0100 k200 k300 k20222024

HANSA BIOPHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k20222024
Filed accounts2022–2024
20222024
Profit for the year-602,7621,336
Cash at bank and in hand21,77749,909
Total assets267,280576,514
Total liabilities161,083294,231
Net assets / total equity108,254283,932
Average number of employees60

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HANSA BIOPHARMA LIMITED

Company

HANSA BIOPHARMA LIMITED is a private limited company registered with Companies House under company number 08361712. It was incorporated on 15 Jan 2013. Its status is active. The registered office is in Godalming (GU7). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Profit for the year was £1,336. Net assets were £283,932, up 162.3% on the previous year. Cash at bank and in hand was £49,909. Total assets were £576,514 and total liabilities £294,231. The company had an average of 0 employees. Figures are available for 2 financial years (2022–2024).

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 29 Jan 2027.